Nov 9, 2023 | Biotech, Frontpage, Impact, News
Investigators led by Neil Kelleher, PhD, professor of Medicine in the Division of Hematology and Oncology and of Biochemistry and Molecular Genetics, have developed an automated technique for imaging and identifying proteoforms in ovarian cancer tissue, according to...
Mar 10, 2023 | Biotech, Frontpage, News, Translation
For most scientists, a major drug discovery happens rarely, if ever, in a lifetime. However, for Northwestern’s Richard (Rick) B. Silverman, the Patrick G. Ryan/Aon Professor, lightning struck in a big way with pregabalin, a compound he discovered in his lab....
Feb 27, 2023 | Biotech, Frontpage, News, Translation
Northwestern Medicine scientists have discovered two ways to preserve diseased upper motor neurons that would normally be destroyed in ALS, based on a study in mice. Upper motor neurons initiate movement, and they degenerate in ALS. These neurons have a...
Jun 6, 2022 | Biotech, Frontpage, News, Translation
Setting audacious goals for technology innovation is a critical component of the Human Proteoform Project, a $1.3 billion movement to weigh and characterize every protein variation, (called proteoforms) in the human body. A new technology announced today,...
May 26, 2022 | Biotech, Event, Frontpage
Biopharma investors, innovators, and industry executives will get an exclusive look at next-generation protein therapeutics developed by Northwestern’s top translational scientists at the fourth annual Biotech by the Lake Investor Summit on June 28, 2022, 9:00 a.m. –...
May 26, 2022 | Biotech, Frontpage, News
Richard Silverman was left in the dark for the last five years of clinical development of the drug he discovered. The Northwestern University professor found out about the first approval of Lyrica, in the last few days of 2004, like most other people: in the...
